A Bayesian Joint model for Longitudinal DAS28 Scores and Competing Risk Informative Drop Out in a Rheumatoid Arthritis Clinical Trial

01/25/2018

∙

Rheumatoid arthritis clinical trials are strategically designed to collect the disease activity score of each patient over multiple clinical visits, meanwhile a patient may drop out before their intended completion due to various reasons. The dropout terminates the longitudinal data collection on the patients activity score. In the presence of informative dropout, that is, the dropout depends on latent variables from the longitudinal process, simply applying a model to analyze the longitudinal outcomes may lead to biased results because the assumption of random dropout is violated. In this paper we develop a data driven Bayesian joint model for modeling DAS28 scores and competing risk informative drop out. The motivating example is a clinical trial of Etanercept and Methotrexate with radiographic Patient Outcomes (TEMPO, Keystone et.al).

READ FULL TEXT

A Bayesian Joint model for Longitudinal DAS28 Scores and Competing Risk Informative Drop Out in a Rheumatoid Arthritis Clinical Trial

Modelling and forecasting patient recruitment in clinical trials with patients' dropout

Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial

A Bayesian Precision Response-adaptive Phase II Clinical Trial Design for Radiotherapies with Competing Risk Survival Outcomes

Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout

An Efficient Doubly-robust Imputation Framework for Longitudinal Dropout, with an Application to an Alzheimer's Clinical Trial

Advanced models for predicting event occurrence in event-driven clinical trials accounting for patient dropout, cure and ongoing recruitment

A Bayesian Nonparametric Model for Predicting Pregnancy Outcomes Using Longitudinal Profiles

A Bayesian Joint model for Longitudinal DAS28 Scores and Competing Risk Informative Drop Out in a Rheumatoid Arthritis Clinical Trial

Related Research

Modelling and forecasting patient recruitment in clinical trials with patients' dropout

Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial

A Bayesian Precision Response-adaptive Phase II Clinical Trial Design for Radiotherapies with Competing Risk Survival Outcomes

Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout

An Efficient Doubly-robust Imputation Framework for Longitudinal Dropout, with an Application to an Alzheimer's Clinical Trial

Advanced models for predicting event occurrence in event-driven clinical trials accounting for patient dropout, cure and ongoing recruitment

A Bayesian Nonparametric Model for Predicting Pregnancy Outcomes Using Longitudinal Profiles